Report copyright - The VERTIS CV Trial · CV, cardiovascular; FDA, Food and Drug Administration; SGLT2, sodium-glucose cotransporter 2. EMPA-REG OUTCOME CANVAS Program DECLARE TIMI 58 VERTIS CV Dec
Please pass captcha verification before submit form
Please pass captcha verification before submit form